HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Puts Squeeze On SnugZ; Promo Product/OTC Drug Manufacturer Warned For CGMP Violations

Executive Summary

Known for its customizable lanyards and eyewear retainers, SnugZ USA, Inc. also manufactures sunscreens and other personal-care items for corporate branding purposes. The FDA inspected the firm’s West Jordan, Utah facility in late 2018, finding significant violations of current good manufacturing practices, according to a warning letter posted to the agency’s website 9 July.

Advertisement

Related Content

Skin Care Firms Get External Analgesic Treatment In FDA Warning Letters

Topics

Advertisement
UsernamePublicRestriction

Register

RS148987

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel